Association Between Palliative Resection of the Primary Tumor and Overall Survival in a Population-Based Cohort of Metastatic Colorectal Cancer Patients

Annals of Surgical Oncology

Volumn 21, Issue 12, 2014, Pages 3917-3923

  Gresham, Gillian ^a   Renouf, Daniel J ^a   Chan, Matthew ^a   Kennecke, Hagen F ^a   Lim, Howard J ^a   Brown, Carl ^a   Cheung, Winson Y ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTATIC COLORECTAL CANCER; OVERALL SURVIVAL; PRIMARY TUMOR; PROPENSITY SCORE; SURVIVAL TIME; TREATMENT OUTCOME; CANADA; CANCER STAGING; COHORT ANALYSIS; COLORECTAL NEOPLASMS; FOLLOW UP; METASTASIS; MORTALITY; PALLIATIVE THERAPY; POSTOPERATIVE COMPLICATION; PROCEDURES; PROGNOSIS; SURVIVAL RATE;

AGED; CANADA; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; PALLIATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROPENSITY SCORE; SURVIVAL RATE;

EID: 84918813657     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3797-0     Document Type: Article

References (27)

1. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.
2. Siegel R, Deepa N, Ahmedin J. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29.
3. Canadian Cancer Society’s Steering Committee on Cancer Statistics. Canadian cancer statistics 2012. Toronto, ON: Canadian Cancer Society; 2012.
4. Howlader N, Noone AM, Krapcho M. SEER cancer statistics review, 1975–2010, National Cancer Institute (2013). http://seer.cancer.gov/csr/1975_2010/. Accessed 30 Aug 2013.
5. Ferrand F, Malka D, Bourredjem A, et al. Impact of primary tumour resection on survival of patients with colorectal cancer and synchronous metastases treated by chemotherapy: results from the multicenter, randomised trial Fédération Francophone de Cancérologie Digestive 9601. Eur J Cancer. 2013;49:90–7.
6. Platell C, Ng S, O’Bichere A, et al. Changing management and survival in patients with stage IV colorectal cancer. Dis Colon Rectum. 2011;54;214–9.
7. Scheer MG, Sloots CE, van der Wilt GJ, et al. Management of patients with asymptomatic colorectal cancer and synchronous irresectable metastases. Ann Oncol. 2008;19:1829–35.
8. Gonsalves WI, Wolpert J, Tashi T, et al. Assessment of prognostic factors after primary tumor resection in metastatic colon cancer patients: a Veteran’s Affairs Central Cancer Registry (VACCR) analysis, 1995–2008. J Surg Oncol. 2012;106:486–90.
9. Aslam MI, Kelkar A, Sharpe D, et al. Ten years experience of managing the primary tumours in patients with stage IV colorectal cancers. Int J Surg. 2010;8:305–13.
10. Karoui M, Roudot-Thoraval F, Mesli F, et al. Primary colectomy in patients with stage IV colon cancer and unresectable distant metastases improves overall survival: results of a multicentric study. Dis Colon Rectum. 2011;54:930–8.
11. Kim YW, Kim IY. The role of surgery for asymptomatic primary tumors in unresectable stage IV colorectal cancer. Ann Coloproctol. 2013;29:44–54.
12. Stillwell AP, Buettner PG, Ho YH. Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone. World J Surg. 2010;34:797–807.
13. Anwar S, Peter MB, Dent J, et al. Palliative excisional surgery for primary colorectal cancer in patients with incurable metastatic disease. Is there a survival benefit? A systematic review. Colorectal Dis. 2012;14:920–30.
14. Eisenberger A, Whelan RL, Neugut A. Survival and symptomatic benefit from palliative primary tumor resection in patients with metastatic colorectal cancer: a review. Int J Colorectal Dis. 2008;23:559–68.
15. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984;79:516–24.
16. D’Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17:2265–81.
17. Hosmer DW, Lemeshow S. Applied logistic regression (2nd edition). New York: John Wiley & Sons; 2000.
18. Cirocchi R, Trastulli S, Abraha I, et al. Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer. Cochrane Database Sys Rev. 2012;8:CD008997.
19. Venderbosch S, de Wilt JH, Teerenstra S, et al. Prognostic value of resection of primary tumor in patients with stage IV colorectal cancer: retrospective analysis of two randomized studies and a review of the literature. Ann Surg Oncol. 2011;18:3252–60.
20. Koopman M, Antonini NF, Douma J, et al. Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer (CAIRO): a phase III randomised controlled trial. Lancet. 2007;370:135–42.
21. Tol J, Koopman M, Rodenburg CJ, et al. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity. Ann Oncol. 2008;19:734–8.
22. de Wilt JH, Verhoef WC, Punt CJ. The role of surgery of the primary tumour with few or-absent symptoms in patients with synchronous unresectable metastases of colon cancer, a randomized phase III study CAIRO 4. DCCG CAIRO4 study, protocol version 1.1 20-8-2012.
23. Flanigan R, Salman S, Blumenstein B, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med. 2001;345:1655–9.
24. Kleepsies A, Fuessi KE, Seeliger H, et al. Determinants of morbidity and survival after elective non-curative resection of stage IV colon and rectal cancer. Int J Colorectal Dis. 2009;24:1097–109.
25. Costi R, Mazzeo A, Di MD, et al. Palliative resection of colorectal cancer: does it prolong survival?. Ann Surg Oncol. 2007;14:2567–76.
26. Poultsides GA, Servais EL, Saltz LB, et al. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol. 2009;27:3379–84.
27. Rahbari, Nuh N, Lordick F, et al. Resection of the primary tumour versus no resection prior to systemic therapy in patients with colon cancer and synchronous unresectable metastases (UICC stage IV): SYNCHRONOUS—a randomised controlled multicentre trial (ISRCTN30964555). BMC Cancer. 2012;12:142.